TGFB1 and osteosarcoma: Recent studies show that the inhibitor of TGF-β signals which are associated with metastasis and chemoresistance of osteosarcoma, LY2109761, could inhibit metastasis and enhances chemosensitivity of osteosarcoma by the downregulation of S100A4 expression [154].